At a glance
- Originator Gilead Sciences
- Class Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 11 Jun 2001 No-Development-Reported for Herpes simplex virus infections in USA (PO)
- 08 Sep 1997 New profile
- 08 Sep 1997 Preclinical development for Herpes simplex virus infections in USA (PO)